KLP Kapitalforvaltning’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
28,820
+1,300
+5% +$397K 0.03% 383
2026
Q1
$6.9M Buy
27,520
+2,120
+8% +$527K 0.03% 428
2025
Q4
$6.99M Hold
25,400
0.03% 433
2025
Q3
$6.66M Hold
25,400
0.03% 439
2025
Q2
$5.56M Buy
25,400
+500
+2% +$107K 0.02% 459
2025
Q1
$5.57M Buy
24,900
+600
+2% +$165K 0.03% 461
2024
Q4
$7.96M Buy
+24,300
New +$7.65M 0.04% 386

Other funds holding WST

KLP Kapitalforvaltning's WST Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its West Pharmaceutical (WST) stake by 4.7% in Q2 2026, buying an estimated $397K and bringing the position to 28,820 shares worth $10.3M. The position accounts for 0.03% of the portfolio, ranked #383.

KLP Kapitalforvaltning first reported a position in WST in Q4 2024 and has held it in 7 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • KLP Kapitalforvaltning held 28,820 shares of West Pharmaceutical worth $10.3M as of Q2 2026.
  • KLP Kapitalforvaltning bought 1,300 West Pharmaceutical shares in Q2 2026, an estimated $397K.
  • West Pharmaceutical made up 0.03% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #383 holding.
  • KLP Kapitalforvaltning first reported a position in West Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.